Project Details
Abstract
Type 2 diabetes (T2D) is a chronic metabolic disorder and one of the leading causes of
disability and mortality worldwide [1]. In 2025, approximately 589 million people were living with diabetes, and global prevalence is projected to rise by nearly 45% by 2050 [2]. The Middle East/North Africa region has the highest regional prevalence of diabetes and the highest diabetes-related mortality globally [2].
Qatar has a high obesity rate [3], with 65–70% of obese adults and driving the country’s escalating T2D burden. In 2012, the Qatar STEPwise Survey reported a T2D prevalence of 16.7% among Qataris. By 2023, this number rose to 18.1% among Qataris and 15.4% among all adults in Qatar [4,5]. The 2025 IDF Diabetes Atlas estimated the prevalence of T2D among adults aged 20–79 at 24.6%, placing Qatar among the top 10 affected countries globally [2]. T2D drives complications across multiple organs. In Qatar, T2D accounts for approximately 50% of dialysis-requiring renal disease and 70% of stroke and transient ischemic attack cases [6]. Annual healthcare expenditure for diabetic patients reached 1.8 billion QAR in 2015 and is projected to rise to 5.0 billion QAR by 2030, a nearly threefold increase in just 15 years [3]. These obesity-associated diabetic complications arise from gene–environment interactions, where epigenetic mechanisms link unhealthy diets and lifestyle factors to metabolic dysregulation [7,8].
Submitting Institute Name
Hamad Bin Khalifa University (HBKU)
| Sponsor's Award Number | HBKU-INT-VPR-JFI-02 |
|---|---|
| Proposal ID | HBKU-OVPR-SIC-01-18 |
| Status | Active |
| Effective start/end date | 3/09/26 → 2/09/28 |
Primary Theme
- Artificial Intelligence
Primary Subtheme
- AI - Healthcare
Secondary Theme
- None
Secondary Subtheme
- None
Keywords
- None
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.